Clindamycin Hydrochloride Capsule, Gelatin Coated
Product Images NDC 69238-2121

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 69238-2121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Clindamycin Hydrochloride Capsules Usp 300mg 1)

FDA Label Image

Blister (Clindamycin Hydrochloride Capsules Usp 300mg 2)

Blister (Clindamycin Hydrochloride Capsules Usp 300mg 2)
This is a document related to a medication with the NDC code 69238-2121-4, which is a Clindamycin HCI capsule manufactured by Amneal Pharmaceuticals. The capsule contains 300 mg of the active ingredient. The document contains several repetitions of the NDC code, medication name, capsule size, and manufacturer's information. The rest of the text is not readable.*
FDA Label Image

Ifc (Clindamycin Hydrochloride Capsules Usp 300mg 3)

Ifc (Clindamycin Hydrochloride Capsules Usp 300mg 3)
Clindamycin HCI Capsules are a medication used to treat bacterial infections. Each capsule contains 300mg of clindamycin HC and is typically taken every six hours. The medication should be stored at room temperature and kept out of reach of children. The full prescription information is available in the package insert. This medication is distributed by Amneal Pharmaceuticals LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.